nicotinamide mononucleotide has been researched along with Atherosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, P; Csipo, T; Csiszar, A; Farkas, E; Gautam, T; Giles, CB; Kiss, T; Lipecz, A; Nyúl-Tóth, Á; Szabo, C; Tarantini, S; Ungvari, Z; Wren, JD; Yabluchanskiy, A | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Atherosclerosis
| Article | Year |
|---|---|
Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.
Topics: Aging; Animals; Aorta; Atherosclerosis; Dietary Supplements; Endothelium, Vascular; Epigenesis, Genetic; Gene Expression Profiling; Mice, Inbred C57BL; MicroRNAs; Nicotinamide Mononucleotide; Rejuvenation | 2019 |